PharmEasy further loses its valuation to $456 million: Report
Health-tech company PharmEasy has drastically lost its valuation to now around $456 million, from its all-time high of $5.6 billion.
Health-tech company PharmEasy has drastically lost its valuation to now around $456 million, from its all-time high of $5.6 billion.
Health-tech company PharmEasy has clocked Rs 2,533 crore in losses last fiscal (FY24), as it revenue declined almost 15 per cent at Rs 5,664 crore.
PharmEasy will also be looking forward to onboarding Medlife's retail partners and continuing their journey with the brand.
